We use cookies for a better user experience. Read our Privacy Policy

I Agree

Wearable Injectors Market

Wearable Injectors Market (Type - On-body Wearable Injectors, Off-body Wearable Injectors; Application - Oncology, Diabetes, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases; End use Industry - Hospitals, Clinics, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

The presence of an ever-expanding healthcare industry has played an integral role in driving sales across the global wearable injectors market. It is integral for patients suffering from chronic diseases to get proper treatment and dosage at regular intervals of time. Wearable injectors have emerged as a self-scalable and self-administered technology that can help patients in ensuring regular intake of medical dosage. The need for administering the right amount of medical fluid has brought wearable injectors under the spotlight of attention. It is important for medical professionals and healthcare experts to inform the masses about the importance of using new-age technologies such as wearable injectors and other devices. The rising incidence of chronic diseases that necessitate the use of seamless technologies shall be a prominent driver of market demand in the times to follow.

In the presence of various new technologies that have come to the fore of healthcare sector, it is easy to popularise wearable injectors that can work in tandem with other devices and technologies. Delivery systems are an important component of treatment processes as they help in timely administration of medical doses. In light of these factors, it is safe to expect that the global wearable injectors market would tread along a lucrative pathway in the times to follow

wearable injectors market

Utility Served by Wearable Devices for Patients of Chronic Diseases

The next decade is expected to witness a surge in demand for wearable injectors, and this is an important consideration from the perspective of market growth. Wearable injectors can help in administering fluids in volumes larger than 2 mL, and this is a key proposition from the standpoint of market maturity. The subcutaneous nature of injecting bodily fluids through wearable injectors has also emerged as an important dynamic of market maturity. Furthermore, wearable injectors can be used to continuously deliver medical dosages over an extended period of time. These injectors and systems can be comfortably worn on the human body, creating new inlets for market growth and maturity.

The utility served by wearable injectors is the most prominent driver of demand within the global market. Several patients have started using wearable injectors as an important medical technology. Furthermore, the unprecedented need for microdevices in the healthcare industry has led doctors to scout for new technologies. In recent times, several experts have come to acknowledge the value of wearable injectors. Besides, the unprecedented demand for new-age technologies within medical diagnosis and treatment has also gained momentum.

Popularity of Wearable Technologies to Drive Demand

The growing relevance of wearable injectors and technologies has created new pathways for market growth and maturity. Several medical experts have pointed to the potential of wearable technologies in helping the medical industry in expediting treatment processes. Minor jumps and medical advances can be a source of relief for patients suffering from chronic illnesses. The hassle of undergoing multiple manual procedures for administration of medical fluids can be extremely traumatizing for patients. Patients suffering from heart diseases, cancer, and diabetes are especially prone to suffering from excessive stress due to frequent exposure to hospitals for minor fluid administration. Therefore, use of wearable injectors has emerged as an important dynamic of market growth and maturity in recent times. It is legit to expect that the growth graph of the global wearable injectors market would ascend along a lucrative pathway in the years to come by.

Need for Convenient Administration of Drugs

The use of wearable injectors has canny resemblance to the popularity of insulin pumps in the medical industry. Therefore, there is immense hope about mainstream usage of wearable injectors across the medical industry. In addition to this, the use of these injectors by patients at home has also given an impetus to market growth. The high costs associated with the use of manual administration lines has brought wearable injectors under the spotlight of attention. It is crucial for the masses to understand that administration of an infusion drug in the hospital will bear more cost and efforts than convenient administration of the drug through wearable injectors. This realization can help in popularising these injectors across a large population of people. Over the course of the next decade, it is legit to expect that the global wearable injectors market would attract voluminous revenues in the times to follow. Some of the common healthcare domains where wearable injectors are playing a revolutionary role are hemophilia, auto-immune, oncology, and multiple sclerosis. The commonality of IV infusion has compelled medical professionals to popularise wearable injectors. This can help in reducing the load on healthcare units and hospitals.

Growth of North America Market

On the basis of geography, the total volume of revenues within the North America wearable injectors market is projected to grow at a sound pace. Other regional pockets such as South America, Europe, Asia Pacific, and the Middle East have also witnessed a surge in demand for wearable injectors. The growth of the North America market can be pegged to advancements in medical research, wearable devices, and fluid administration. Furthermore, the growing focus on developing novel technologies for subcutaneous administration of fluids has also garnered the attention of the healthcare fraternity. Wearable injectors can be scaled for the amount of dosage and time that is apt for fluid administration. This is an important standpoint for popularising and promoting these injectors.

Some of the prominent vendors operating in the global wearable injectors market are F. Hoffmann-La Roche Ltd., Insulet Corporation, Ypsomed AG, Tandem Diabetes Care, Inc., and West Pharmaceutical Services, Inc.

The global wearable injectors market has been segmented as follows:

by Type

  • On-body Wearable Injectors
  • Off-body Wearable Injectors

by Application

  • Oncology
  • Diabetes
  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

by End-user

  • Hospitals
  • Clinics
  • Home Care Settings
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

    1. Preface
         1.1. Report Scope and Market Segmentation
         1.2. Research Highlights

    2. Assumptions and Research Methodology
         2.1. Assumptions
         2.2. Acronyms Used
         2.3. Research Methodology

    3. Executive Summary
         3.1. Global Wearable Injectors Market Snapshot

    4. Market Overview
         4.1. Product Overview
         4.2. Market Opportunity Map
         4.3. Key Industry Events
         4.4. Global Wearable Injectors Market Size (US$ Mn) Forecast, 2016–2026
         4.5. Global Wearable Injectors Market Outlook
         4.6. Porter’s Five Forces Analysis
         4.7. Technology Trends
         4.8. Key Merger and Acquisitions

    5. Market Dynamics
         5.1. Drivers and Restraints Snapshot Analysis
         5.2. Drivers
         5.3. Restraints
         5.4. Opportunities

    6. Global Wearable Injectors Market Analysis, by Type
         6.1. Key Findings
         6.2. Introduction
         6.3. Global Wearable Injectors Market Value Share Analysis, by Type
         6.4. Global Wearable Injectors Market Forecast, by Type
                6.4.1. On-body Wearable Injectors
                6.4.2. Off-body Wearable Injectors
         6.5. Global Wearable Injectors Market Analysis, by Type
         6.6. Global Wearable Injectors Market Attractiveness Analysis, by Type

    7. Global Wearable Injectors Market Analysis, by Application
         7.1. Key Findings
         7.2. Introduction
         7.3. Global Wearable Injectors Market Value Share Analysis, by Application, 2017 and 2026
         7.4. Global Wearable Injectors Market Forecast, by Application
                7.4.1. Oncology
                7.4.2. Diabetes
                7.4.3. Autoimmune Disorders
                7.4.4. Cardiovascular Diseases
                7.4.5. Infectious Diseases
                7.4.6. Others
         7.5. Global Wearable Injectors Market Analysis, by Application, 2016–2026
         7.6. Global Wearable Injectors Market Attractiveness Analysis, by Application, 2016–2026

    8. Global Wearable Injectors Market Analysis, by End-user
         8.1. Introduction
         8.2. Key Findings
         8.3. Global Wearable Injectors Market Value Share Analysis, by End-user
         8.4. Global Wearable Injectors Market Forecast, by End-user
                8.4.1. Hospitals
                8.4.2. Clinics
                8.4.3. Home Care Settings
                8.4.4. Others
         8.5. Global Wearable Injectors Market Analysis, by End-user
         8.6. Global Wearable Injectors Market Attractiveness Analysis, by End-user

    9. Global Wearable Injectors Market Analysis, by Region
         9.1. Global Wearable Injectors Market Scenario, by Region
         9.2. Global Wearable Injectors Market Value Share Analysis, by Region
         9.3. Global Wearable Injectors Market Forecast, by Region
                9.3.1. North America
                9.3.2. Europe
                9.3.3. Asia Pacific
                9.3.4. Latin America
                9.3.5. Middle East & Africa
         9.4. Global Wearable Injectors Market Attractiveness Analysis, by Region

    10. North America Wearable Injectors Market Analysis
         10.1. Key Findings
         10.2. North America Wearable Injectors Market Overview
         10.3. North America Wearable Injectors Market Value Share Analysis, by Country
         10.4. North America Wearable Injectors Market Forecast, by Country
                10.4.1. U.S.
                10.4.2. Canada
         10.5. North America Wearable Injectors Market Value Share Analysis, by Type
         10.6. North America Wearable Injectors Market Forecast, by Type
                10.6.1. On-body Wearable Injectors
                10.6.2. Off-body Wearable Injectors
         10.7. North America Wearable Injectors Market Value Share Analysis, by Application
         10.8. North America Wearable Injectors Market Forecast, by Application
                10.8.1. Oncology
                10.8.2. Diabetes
                10.8.3. Autoimmune Disorders
                10.8.4. Cardiovascular Diseases
                10.8.5. Infectious Diseases
                10.8.6. Others
         10.9. North America Wearable Injectors Market Value Share Analysis, by End-user
         10.10. North America Wearable Injectors Market Forecast, by End-user
                10.10.1. Hospitals
                10.10.2. Clinics
                10.10.3. Home Care Settings
                10.10.4. Others
         10.11. North America Wearable Injectors Market Attractiveness Analysis

    11. Europe Wearable Injectors Market Analysis
         11.1. Key Findings
         11.2. Europe Wearable Injectors Market Overview
         11.3. Europe Wearable Injectors Market Value Share Analysis, by Country/Sub-region
         11.4. Europe Wearable Injectors Market Forecast, by Country/Sub-region
                11.4.1. Germany
                11.4.2. U.K.
                11.4.3. France
                11.4.4. Italy
                11.4.5. Spain
                11.4.6. Rest of Europe
         11.5. Europe Wearable Injectors Market Value Share Analysis, by Type
         11.6. Europe Wearable Injectors Market Forecast, by Type
                11.6.1. On-body Wearable Injectors
                11.6.2. Off-body Wearable Injectors
         11.7. Europe Wearable Injectors Market Value Share Analysis, by Application
         11.8. Europe Wearable Injectors Market Forecast, by Application
                11.8.1. Oncology
                11.8.2. Diabetes
                11.8.3. Autoimmune Disorders
                11.8.4. Cardiovascular Diseases
                11.8.5. Infectious Diseases
                11.8.6. Others
         11.9. Europe Wearable Injectors Market Value Share Analysis, by End-user
         11.10. Europe Wearable Injectors Market Forecast, by End-user
                11.10.1. Hospitals
                11.10.2. Clinics
                11.10.3. Home Care Settings
                11.10.4. Others
         11.11. Europe Wearable Injectors Market Attractiveness Analysis

    12. Asia Pacific Wearable Injectors Market Analysis
         12.1. Key Findings
         12.2. Asia Pacific Wearable Injectors Market Overview
         12.3. Asia Pacific Wearable Injectors Market Value Share Analysis, by Country/Sub-region
         12.4. Asia Pacific Wearable Injectors Market Forecast, by Country/Sub-region
                12.4.1. China
                12.4.2. Japan
                12.4.3. India
                12.4.4. Australia & New Zealand
                12.4.5. Rest of Asia Pacific
         12.5. Asia Pacific Wearable Injectors Market Value Share Analysis, by Type
         12.6. Asia Pacific Wearable Injectors Market Forecast, by Type
                12.6.1. On-body Wearable Injectors
                12.6.2. Off-body Wearable Injectors
         12.7. Asia Pacific Wearable Injectors Market Value Share Analysis, by Application
         12.8. Asia Pacific Wearable Injectors Market Forecast, by Application
                12.8.1. Oncology
                12.8.2. Diabetes
                12.8.3. Autoimmune Disorders
                12.8.4. Cardiovascular Diseases
                12.8.5. Infectious Diseases
                12.8.6. Others
         12.9. Asia Pacific Wearable Injectors Market Value Share Analysis, by End-user
         12.10. Asia Pacific Wearable Injectors Market Forecast, by End-user
                12.10.1. Hospitals
                12.10.2. Clinics
                12.10.3. Home Care Settings
                12.10.4. Others
         12.11. Asia Pacific Wearable Injectors Market Attractiveness Analysis

    13. Latin America Wearable Injectors Market Analysis
         13.1. Key Findings
         13.2. Latin America Wearable Injectors Market Overview
         13.3. Latin America Wearable Injectors Market Value Share Analysis, by Country/Sub-region
         13.4. Latin America Wearable Injectors Market Forecast, by Country/Sub-region
                13.4.1. Brazil
                13.4.2. Mexico
                13.4.3. Rest of Latin America
         13.5. Latin America Wearable Injectors Market Value Share Analysis, by Type
         13.6. Latin America Wearable Injectors Market Forecast, by Type
                13.6.1. On-body Wearable Injectors
                13.6.2. Off-body Wearable Injectors
         13.7. Latin America Wearable Injectors Market Value Share Analysis, by Application
         13.8. Latin America Wearable Injectors Market Forecast, by Application
                13.8.1. Oncology
                13.8.2. Diabetes
                13.8.3. Autoimmune Disorders
                13.8.4. Cardiovascular Diseases
                13.8.5. Infectious Diseases
                13.8.6. Others
         13.9. Latin America Wearable Injectors Market Value Share Analysis, by End-user
         13.10. Latin America Wearable Injectors Market Forecast, by End-user
                13.10.1. Hospitals
                13.10.2. Clinics
                13.10.3. Home Care Settings
                13.10.4. Others
         13.11. Latin America Wearable Injectors Market Attractiveness Analysis

    14. Middle East and Africa Wearable Injectors Market Analysis
         14.1. Key Findings
         14.2. Middle East and Africa Wearable Injectors Market Overview
         14.3. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Country/Sub-region
         14.4. Middle East and Africa Wearable Injectors Market Forecast, by Country/Sub-region
                14.4.1. GCC Countries
                14.4.2. South Africa
                14.4.3. Rest of MEA
         14.5. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Type
         14.6. Middle East and Africa Wearable Injectors Market Forecast, by Type
                14.6.1. On-body Wearable Injectors
                14.6.2. Off-body Wearable Injectors
         14.7. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Application
         14.8. Middle East and Africa Wearable Injectors Market Forecast, by Application
                14.8.1. Oncology
                14.8.2. Diabetes
                14.8.3. Autoimmune Disorders
                14.8.4. Cardiovascular Diseases
                14.8.5. Infectious Diseases
                14.8.6. Others
         14.9. Middle East and Africa Wearable Injectors Market Value Share Analysis, by End-user
         14.10. Middle East and Africa Wearable Injectors Market Forecast, by End-user
                14.10.1. Hospitals
                14.10.2. Clinics
                14.10.3. Home Care Settings
                14.10.4. Others
         14.11. Middle East and Africa Wearable Injectors Market Attractiveness Analysis

    15. Competition Landscape
         15.1. Wearable Injectors Market Share Analysis By Company, 2017
         15.2. Company Profiles
                15.2.1. Becton, Dickinson and Company
                         15.2.1.1. Company Profiles
                         15.2.1.2. Business Overview
                         15.2.1.3. Strategic Overview
                         15.2.1.4. SWOT Analysis
                15.2.2. F. Hoffmann-La Roche Ltd.
                         15.2.2.1. Company Profiles
                         15.2.2.2. Business Overview
                         15.2.2.3. Strategic Overview
                         15.2.2.4. SWOT Analysis
                15.2.3. Tandem Diabetes Care, Inc.
                         15.2.3.1. Company Profiles
                         15.2.3.2. Business Overview
                         15.2.3.3. Strategic Overview
                         15.2.3.4. SWOT Analysis
                15.2.4. Insulet Corporation
                         15.2.4.1. Company Profiles
                         15.2.4.2. Business Overview
                         15.2.4.3. Strategic Overview
                         15.2.4.4. SWOT Analysis
                15.2.5. Ypsomed AG
                         15.2.5.1. Company Profiles
                         15.2.5.2. Business Overview
                         15.2.5.3. Strategic Overview
                         15.2.5.4. SWOT Analysis
                15.2.6. West Pharmaceutical Services, Inc.
                         15.2.6.1. Company Profiles
                         15.2.6.2. Business Overview
                         15.2.6.3. Strategic Overview
                         15.2.6.4. SWOT Analysis
                15.2.7. CeQur SA.
                         15.2.7.1. Company Profiles
                         15.2.7.2. Business Overview
                         15.2.7.3. Strategic Overview
                         15.2.7.4. SWOT Analysis
                15.2.8. Debiotech S.A.
                         15.2.8.1. Company Profiles
                         15.2.8.2. Business Overview
                         15.2.8.3. Strategic Overview
                         15.2.8.4. SWOT Analysis
                15.2.9. Sensile Medical AG
                         15.2.9.1. Company Profiles
                         15.2.9.2. Business Overview
                         15.2.9.3. Strategic Overview
                         15.2.9.4. SWOT Analysis
                15.2.10. SteadyMed Therapeutics, Inc.
                         15.2.10.1. Company Profiles
                         15.2.10.2. Business Overview
                         15.2.10.3. Strategic Overview
                         15.2.10.4. SWOT Analysis

    List of Tables

    Table 01: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
    Table 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 03: Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 04: Global Wearable Injectors Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
    Table 05: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2016–2026
    Table 06: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
    Table 07: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 08: North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 09: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 10: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
    Table 11: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 12: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 13: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 14: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
    Table 15: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 16: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 17: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 18: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
    Table 19: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 20: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 21: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 22: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
    Table 23: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 24: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures

    Figure 01: Global Wearable Injectors Market Snapshot
    Figure 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, 2016–2026
    Figure 03: Market Value Share, by Type (2017)
    Figure 04: Market Value Share, by Application (2017)
    Figure 05: Market Value Share, by Region (2017)
    Figure 06: Figure 06: Market Value Share, by End-user (2017)
    Figure 07: Global Wearable Injectors Market Value Share Analysis, by Type, 2017 and 2026
    Figure 08: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by On-body wearable injectors, 2016–2026
    Figure 09: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Off-body wearable injectors, 2016–2026
    Figure 10: Global Wearable Injectors Market Attractiveness Analysis, by Type, 2016–2026
    Figure 11: Global Wearable Injectors Market Value Share Analysis, by Application, 2016 and 2025
    Figure 12: Global Wearable Injectors Market Size (US$ Mn), by Oncology, 2016–2026
    Figure 13: Global Wearable Injectors Market Size (US$ Mn), by Diabetes, 2016–2026
    Figure 14: Global Wearable Injectors Market Size (US$ Mn), by Autoimmune Disorders, 2016–2026
    Figure 15: Global Wearable Injectors Market Size (US$ Mn), by Cardiovascular Diseases, 2016–2026
    Figure 16: Global Wearable Injectors Market Size (US$ Mn), by Infectious Diseases, 2016–2026
    Figure 17: Global Wearable Injectors Market Size (US$ Mn), by Others, 2016–2026
    Figure 18: Global Wearable Injectors Market Attractiveness Analysis, by Application, 2018–2026
    Figure 19: Global Wearable Injectors Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 20: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
    Figure 21: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016–2026
    Figure 22: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Home Care Settings, 2016–2026
    Figure 23: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Others (Physician office, etc.), 2016–2026
    Figure 24: Global Wearable Injectors Market Attractiveness Analysis, by End-user, 2016–2026
    Figure 25: Global Wearable Injectors Market Value Share, by Region, 2017 and 2026
    Figure 26: Global Wearable Injectors Market Attractiveness, by Region, 2018–2026
    Figure 27: North America Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 28: North America Wearable Injectors Market Attractiveness, by Country, 2018–2026
    Figure 29: North America Wearable Injectors Market Value Share, by Country, 2017 and 2026
    Figure 30: North America Wearable Injectors Market Value Share, by Type, 2017 and 2026
    Figure 31: North America Wearable Injectors Market Value Share, by Application, 2017 and 2026
    Figure 32: North America Wearable Injectors Market Value Share, by End-user, 2017 and 2026
    Figure 33: North America Wearable Injectors Market Attractiveness, by Type, 2016–2026
    Figure 34: North America Wearable Injectors Market Attractiveness, by End-user, 2016–2026
    Figure 35: North America Wearable Injectors Market Attractiveness, by Application, 2016–2026
    Figure 36: Europe Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 37: Europe Wearable Injectors Market Attractiveness, by Country, 2018–2026
    Figure 38: Europe Wearable Injectors Market Value Share, by Country, 2017 and 2026
    Figure 39: Europe Wearable Injectors Market Value Share, by Type, 2017 and 2026
    Figure 40: Europe Wearable Injectors Market Value Share, by Application, 2017 and 2026
    Figure 41: Europe Wearable Injectors Market Value Share, by End-user, 2017 and 2026
    Figure 42: Europe Wearable Injectors Market Attractiveness, by Type, 2016–2026
    Figure 43: Europe Wearable Injectors Market Attractiveness, by End-user, 2016–2026
    Figure 44: Europe Wearable Injectors Market Attractiveness, by Application, 2016–2026
    Figure 45: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 46: Asia Pacific Wearable Injectors Market Attractiveness, by Country, 2018–2026
    Figure 47: Asia Pacific Wearable Injectors Market Value Share, by Country, 2017 and 2026
    Figure 48: Asia Pacific Wearable Injectors Market Value Share, by Type, 2017 and 2026
    Figure 49: Asia Pacific Wearable Injectors Market Value Share, by Application, 2017 and 2026
    Figure 50: Asia Pacific Wearable Injectors Market Value Share, by End-user, 2017 and 2026
    Figure 51: Asia Pacific Wearable Injectors Market Attractiveness, by Type, 2016–2026
    Figure 52: Asia Pacific Wearable Injectors Market Attractiveness, by End-user, 2016–2026
    Figure 53: Asia Pacific Wearable Injectors Market Attractiveness, by Application, 2016–2026
    Figure 54: Latin America Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 55: Latin America Wearable Injectors Market Attractiveness, by Country, 2018–2026
    Figure 56: Latin America Wearable Injectors Market Value Share, by Country, 2017 and 2026
    Figure 57: Latin America Wearable Injectors Market Value Share, by Type, 2017 and 2026
    Figure 58: Latin America Wearable Injectors Market Value Share, by Application, 2017 and 2026
    Figure 59: Latin America Wearable Injectors Market Value Share, by End-user, 2017 and 2026
    Figure 60: Latin America Wearable Injectors Market Attractiveness, by Type, 2016–2026
    Figure 61: Latin America Wearable Injectors Market Attractiveness, by End-user, 2016–2026
    Figure 62: Latin America Wearable Injectors Market Attractiveness, by Application, 2016–2026
    Figure 63: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 64: Middle East & Africa Wearable Injectors Market Attractiveness, by Country, 2018–2026
    Figure 65: Middle East & Africa Wearable Injectors Market Value Share, by Country, 2017 and 2026
    Figure 66: Middle East & Africa Wearable Injectors Market Value Share, by Type, 2017 and 2026
    Figure 67: Middle East & Africa Wearable Injectors Market Value Share, by Application, 2017 and 2026
    Figure 68: Middle East & Africa Wearable Injectors Market Value Share, by End-user, 2017 and 2026
    Figure 69: Middle East & Africa Wearable Injectors Market Attractiveness, by Type, 2016–2026
    Figure 70: Middle East & Africa Wearable Injectors Market Attractiveness, by End-user, 2016–2026
    Figure 71: Middle East & Africa Wearable Injectors Market Attractiveness, by Application, 2016–2026
    Figure 72: Becton, Dickinson and Company, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
    Figure 73: Becton, Dickinson and Company, Breakdown of Net Sales, By Region (Pharmaceutical Segment), 2017
    Figure 74: Becton, Dickinson and Company, R&D Intensity (%) – Company Level or Segment Level, 2014–2017
    Figure 75: Hoffmann-La Roche Ltd., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
    Figure 76: Hoffmann-La Roche Ltd., Breakdown of Net Sales, By Region (Pharmaceutical Segment), 2017
    Figure 77: Hoffmann-La Roche Ltd., R&D Intensity (%) – Company Level or Segment Level, 2014–2017
    Figure 78: Tandem Diabetes Care, Inc., R&D Intensity (%) – Company Level or Segment Level, 2014–2017
    Figure 79: Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
    Figure 80: Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
    Figure 81: Insulet Corporation, Breakdown of Net Sales, By Region, 2016
    Figure 82: Insulet Corporation, R&D Intensity (%) – Company Level or Segment Level, 2014–2017
    Figure 83: Ypsomed AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
    Figure 84: Ypsomed AG, Breakdown of Net Sales, By Region, 2016
    Figure 85: Ypsomed AG, R&D Intensity (%) – Company Level or Segment Level, 2013–2016
    Figure 86: West Pharmaceutical Services, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
    Figure 87: West Pharmaceutical Services, Inc., Breakdown of Net Sales, By Region, 2016
    Figure 88: West Pharmaceutical Services, Inc., R&D Intensity (%) – Company Level or Segment Level, 2014–2017

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved